BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 2606418)

  • 1. [Chronic myeloproliferative diseases. 3: Osteomyelofibrosis].
    Zankovich R
    Fortschr Med; 1989 Nov; 107(34):736-40. PubMed ID: 2606418
    [No Abstract]   [Full Text] [Related]  

  • 2. [So-called primary (idiopathic) osteomyelofibrosis/-sclerosis (OMF) within the scope of chronic myeloproliferative diseases. II. Course and therapy in 102 patients with special reference to early hyperplastic and advanced fibrosclerotic stages].
    Zankovich R; Thiele J; Mödder B; Steinberg T; Simon KG; Fischer R; Diehl V
    Med Klin (Munich); 1988 Oct; 83(19):629-36. PubMed ID: 3185421
    [No Abstract]   [Full Text] [Related]  

  • 3. [So-called primary (idiopathic) osteomyelofibrosis/-sclerosis (OMF) within the scope of chronic myeloproliferative diseases. I. Initial clinical and histologic findings in 102 patients with special reference to early hyperplastic and advanced fibrosclerotic stages].
    Zankovich R; Thiele J; Mödder B; Steinberg T; Simon KG; Fischer R; Diehl V
    Med Klin (Munich); 1988 Oct; 83(19):617-28. PubMed ID: 3185420
    [No Abstract]   [Full Text] [Related]  

  • 4. Myelofibrosis in myeloproliferative disorders.
    Srinivasan U; Talvalkar GV; Advani SH
    Indian J Cancer; 1978 Sep; 15(3):37-43. PubMed ID: 294411
    [No Abstract]   [Full Text] [Related]  

  • 5. Idiopathic myelofibrosis. Clinical aspects and studies on extracellular matrix metabolism.
    Hasselbalch HC
    Dan Med Bull; 1993 Mar; 40(1):39-55. PubMed ID: 8472598
    [No Abstract]   [Full Text] [Related]  

  • 6. [Acute osteomyelofibrosis. An overview and 2 personal cases].
    Strebel U; Schaffner A; Fehr J
    Schweiz Med Wochenschr; 1983 Jun; 113(23):844-50. PubMed ID: 6576466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myelofibrosis revisited: characterization and classification of myelofibrosis in the setting of myeloproliferative disease.
    Gilbert HS
    Prog Clin Biol Res; 1984; 154():3-17. PubMed ID: 6382299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Osteomyelofibrosis as a prognostic factor in myeloproliferative diseases?].
    Wehmeier A; Schneider W
    Dtsch Med Wochenschr; 1993 May; 118(21):804-5. PubMed ID: 8504717
    [No Abstract]   [Full Text] [Related]  

  • 9. [Atypical myeloproliferative disorders: a study on 3 cases showing pancytopenia, marrow fibrosis and the absence of splenomegaly].
    Yoshida Y; Yamagishi M; Fukuhara S; Sawada H; Ohkuma M; Uchino H; Nakamura T
    Rinsho Ketsueki; 1984 Mar; 25(3):383-92. PubMed ID: 6471435
    [No Abstract]   [Full Text] [Related]  

  • 10. [Myelofibrosis].
    Marton PF
    Tidsskr Nor Laegeforen; 1974 Nov; 94(32):2255-60. PubMed ID: 4439382
    [No Abstract]   [Full Text] [Related]  

  • 11. Unusual presentation of myelofibrosis.
    Naina HV; Harris S
    Intern Med J; 2008 Jan; 38(1):70-1. PubMed ID: 18190422
    [No Abstract]   [Full Text] [Related]  

  • 12. Primary autoimmune myelofibrosis: definition of a distinct clinicopathologic syndrome.
    Pullarkat V; Bass RD; Gong JZ; Feinstein DI; Brynes RK
    Am J Hematol; 2003 Jan; 72(1):8-12. PubMed ID: 12508261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relevance of bone marrow features in the differential diagnosis between essential thrombocythemia and early stage idiopathic myelofibrosis.
    Thiele J; Kvasnicka HM; Zankovich R; Diehl V
    Haematologica; 2000 Nov; 85(11):1126-34. PubMed ID: 11064463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinicopathologic conference. Chronic myeloproliferative disease with an increase in platelet count in the differential diagnosis of primary (essential, idiopathic) thrombocythemia (PTH)].
    Zankovich R; Thiele J; Fischer R; Diehl V
    Med Klin (Munich); 1986 Jan; 81(1):31-5. PubMed ID: 3785010
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinicopathologic conference. Acute myeloid leukemia with accompanying fibrosis: on the differential diagnosis of an increase in fibers in acute myeloproliferative diseases].
    Zankovich R; Klein H; Thiele J; Diehl V
    Med Klin (Munich); 1986 Dec; 81(25-26):837-42. PubMed ID: 3469494
    [No Abstract]   [Full Text] [Related]  

  • 16. Mechanism of myelofibrosis in chronic myeloproliferative disorders.
    Yonekura S
    Tokai J Exp Clin Med; 1987 Sep; 12(3):141-5. PubMed ID: 3331217
    [No Abstract]   [Full Text] [Related]  

  • 17. [Bone marrow fibrosis in malignant hemopathies and cancers. Histological study of 2 786 biopsies (author's transl)].
    Duhamel G; Stachowiak J
    Sem Hop; 1981 Jan 18-25; 57(3-4):111-6. PubMed ID: 6261348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myelofibrosis with myeloid metaplasia with fatty bone marrow: report of a new case.
    Gerli GC; Gianelli U; Carraro MC; Bestetti A; Marchetti M; Barosi G
    Haematologica; 2001 Aug; 86(8):885-6. PubMed ID: 11524257
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinicopathologic conference. Osteomyelofibrosis/-sclerosis: clinical documentation of a 12-year-long course with sequential biopsies of bone marrow and chromosome analyses].
    Zankovich R; Thiele J; Fischer R; Diehl V
    Med Klin (Munich); 1986 Feb; 81(3):105-11. PubMed ID: 3785064
    [No Abstract]   [Full Text] [Related]  

  • 20. [Pathogenesis of osteomyelofibrosis. Clinical and animal experiment studies].
    Hauswaldt C
    Fortschr Med; 1972 Apr; 90(12):475-8. PubMed ID: 4641329
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.